BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines 2016 Plan — Share Options Cancelled / Lapsed During Month (options)
HKEX Form FF301 Monthly Returns (06160.HK)
Latest, Sep 2026
1,073,566
Period ended Sep 28, 2026
Change on a year earlier
+37.6%
780,160 in Sep 2025
History
63 months
Since Jul 2021
Sources
63
Documents cited below
Monthly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2016 Plan — Share Options Cancelled / Lapsed During Month (options) | Year on year | Source |
|---|---|---|---|---|
| Sep 2026 | Sep 28, 2026 | 1,073,566 | +37.6% | HKEX FF301 (2026-09) ↗ |
| Aug 2026 | Aug 28, 2026 | 511,667 | -26.7% | HKEX FF301 (2026-08) ↗ |
| Jul 2026 | Jul 28, 2026 | 625,217 | -41.2% | HKEX FF301 (2026-07) ↗ |
| Jun 2026 | Jun 28, 2026 | 1,062,633 | -11.3% | HKEX FF301 (2026-06) ↗ |
| May 2026 | May 28, 2026 | 234,117 | -45.0% | HKEX FF301 (2026-05) ↗ |
| Apr 2026 | Apr 28, 2026 | 341,913 | -70.4% | HKEX FF301 (2026-04) ↗ |
| Mar 2026 | Mar 28, 2026 | 684,112 | -68.6% | HKEX FF301 (2026-03) ↗ |
| Feb 2026 | Feb 28, 2026 | 729,963 | -34.1% | HKEX FF301 (2026-02) ↗ |
| Jan 2026 | Jan 28, 2026 | 703,456 | -2.5% | HKEX FF301 (2026-01) ↗ |
| Dec 2025 | Dec 28, 2025 | 698,763 | -38.1% | HKEX FF301 (2025-12) ↗ |
| Nov 2025 | Nov 28, 2025 | 530,036 | -25.7% | HKEX FF301 (2025-11) ↗ |
| Oct 2025 | Oct 28, 2025 | 667,298 | +8.8% | HKEX FF301 (2025-10) ↗ |
| Sep 2025 | Sep 28, 2025 | 780,160 | -58.2% | HKEX FF301 (2025-09) ↗ |
| Aug 2025 | Aug 28, 2025 | 698,230 | -49.9% | HKEX FF301 (2025-08) ↗ |
| Jul 2025 | Jul 28, 2025 | 1,062,433 | +9.8% | HKEX FF301 (2025-07) ↗ |
| Jun 2025 | Jun 28, 2025 | 1,197,501 | -20.8% | HKEX FF301 (2025-06) ↗ |
| May 2025 | May 28, 2025 | 425,355 | -2.5% | HKEX FF301 (2025-05) ↗ |
| Apr 2025 | Apr 28, 2025 | 1,153,204 | +76.2% | HKEX FF301 (2025-04) ↗ |
| Mar 2025 | Mar 28, 2025 | 2,176,473 | +67.6% | HKEX FF301 (2025-03) ↗ |
| Feb 2025 | Feb 28, 2025 | 1,107,561 | +148.4% | HKEX FF301 (2025-02) ↗ |
| Jan 2025 | Jan 28, 2025 | 721,656 | +40.8% | HKEX FF301 (2025-01) ↗ |
| Dec 2024 | Dec 28, 2024 | 1,128,361 | +6.2% | HKEX FF301 (2024-12) ↗ |
| Nov 2024 | Nov 28, 2024 | 713,401 | +162.4% | HKEX FF301 (2024-11) ↗ |
| Oct 2024 | Oct 28, 2024 | 613,346 | -8.1% | HKEX FF301 (2024-10) ↗ |
| Sep 2024 | Sep 28, 2024 | 1,864,621 | +218.0% | HKEX FF301 (2024-09) ↗ |
| Aug 2024 | Aug 28, 2024 | 1,394,576 | +110.5% | HKEX FF301 (2024-08) ↗ |
| Jul 2024 | Jul 28, 2024 | 967,733 | -2.6% | HKEX FF301 (2024-07) ↗ |
| Jun 2024 | Jun 28, 2024 | 1,512,690 | +133.8% | HKEX FF301 (2024-06) ↗ |
| May 2024 | May 28, 2024 | 436,312 | +115.6% | HKEX FF301 (2024-05) ↗ |
| Apr 2024 | Apr 28, 2024 | 654,628 | +53.1% | HKEX FF301 (2024-04) ↗ |
| Mar 2024 | Mar 28, 2024 | 1,298,539 | +129.0% | HKEX FF301 (2024-03) ↗ |
| Feb 2024 | Feb 28, 2024 | 445,939 | +47.3% | HKEX FF301 (2024-02) ↗ |
| Jan 2024 | Jan 28, 2024 | 512,382 | -5.6% | HKEX FF301 (2024-01) ↗ |
| Dec 2023 | Dec 28, 2023 | 1,062,256 | -7.3% | HKEX FF301 (2023-12) ↗ |
| Nov 2023 | Nov 28, 2023 | 271,895 | -51.2% | HKEX FF301 (2023-11) ↗ |
| Oct 2023 | Oct 28, 2023 | 667,405 | -0.4% | HKEX FF301 (2023-10) ↗ |
| Sep 2023 | Sep 28, 2023 | 586,374 | -24.4% | HKEX FF301 (2023-09) ↗ |
| Aug 2023 | Aug 28, 2023 | 662,597 | -40.5% | HKEX FF301 (2023-08) ↗ |
| Jul 2023 | Jul 28, 2023 | 994,071 | -56.0% | HKEX FF301 (2023-07) ↗ |
| Jun 2023 | Jun 28, 2023 | 647,075 | +0.9% | HKEX FF301 (2023-06) ↗ |
| May 2023 | May 28, 2023 | 202,384 | -46.5% | HKEX FF301 (2023-05) ↗ |
| Apr 2023 | Apr 28, 2023 | 427,605 | -36.5% | HKEX FF301 (2023-04) ↗ |
| Mar 2023 | Mar 28, 2023 | 567,057 | +17.4% | HKEX FF301 (2023-03) ↗ |
| Feb 2023 | Feb 28, 2023 | 302,746 | +7.2% | HKEX FF301 (2023-02) ↗ |
| Jan 2023 | Jan 28, 2023 | 542,742 | +98.7% | HKEX FF301 (2023-01) ↗ |
| Dec 2022 | Dec 28, 2022 | 1,146,014 | +195.0% | HKEX FF301 (2022-12) ↗ |
| Nov 2022 | Nov 28, 2022 | 557,609 | -39.1% | HKEX FF301 (2022-11) ↗ |
| Oct 2022 | Oct 28, 2022 | 669,799 | -8.6% | HKEX FF301 (2022-10) ↗ |
| Sep 2022 | Sep 28, 2022 | 775,863 | -43.7% | HKEX FF301 (2022-09) ↗ |
| Aug 2022 | Aug 28, 2022 | 1,114,295 | +161.5% | HKEX FF301 (2022-08) ↗ |
| Jul 2022 | Jul 28, 2022 | 2,261,484 | +128.3% | HKEX FF301 (2022-07) ↗ |
| Jun 2022 | Jun 28, 2022 | 641,422 | – | HKEX FF301 (2022-06) ↗ |
| May 2022 | May 28, 2022 | 378,482 | – | HKEX FF301 (2022-05) ↗ |
| Apr 2022 | Apr 28, 2022 | 672,997 | – | HKEX FF301 (2022-04) ↗ |
| Mar 2022 | Mar 28, 2022 | 482,846 | – | HKEX FF301 (2022-03) ↗ |
| Feb 2022 | Feb 28, 2022 | 282,374 | – | HKEX FF301 (2022-02) ↗ |
| Jan 2022 | Jan 28, 2022 | 273,140 | – | HKEX FF301 (2022-01) ↗ |
| Dec 2021 | Dec 28, 2021 | 388,475 | – | HKEX FF301 (2021-12) ↗ |
| Nov 2021 | Nov 28, 2021 | 915,058 | – | HKEX FF301 (2021-11) ↗ |
| Oct 2021 | Oct 28, 2021 | 733,132 | – | HKEX FF301 (2021-10) ↗ |
| Sep 2021 | Sep 28, 2021 | 1,377,899 | – | HKEX FF301 (2021-09) ↗ |
| Aug 2021 | Aug 28, 2021 | 426,179 | – | HKEX FF301 (2021-08) ↗ |
| Jul 2021 | Jul 28, 2021 | 990,752 | – | HKEX FF301 (2021-07) ↗ |
Cite this data
StockData. (2026). BeOne Medicines 2016 Plan — Share Options Cancelled / Lapsed During Month (options), monthly Jul 2021–Sep 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/hkex_opt_cancelled
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.